Are Non-Invasive Modalities for the Assessment of Atherosclerosis Useful for Heart Failure Predictions?

Kazuhiro Osawa1, Toru Miyoshi2

  • 1Department of General Internal Medicine 3, Kawasaki Medical School General Medical Center, Okayama 700-0821, Japan.

Insights

Non-invasive atherosclerosis assessments effectively predict heart failure (HF) risk, especially when left ventricular ejection fraction is reduced. Further research is needed for HF with preserved ejection fraction.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Medical Imaging

Background:

  • Heart failure (HF) is a growing global health concern with substantial morbidity and mortality.
  • Preventing HF is a critical clinical objective.
  • Traditional cardiovascular disease risk predictors have limitations in assessing HF risk.

Purpose of the Study:

  • To review the clinical significance of non-invasive atherosclerosis assessment modalities.
  • To examine the utility of these modalities in predicting heart failure risk.
  • To explore the influence of left ventricular ejection fraction on predictive accuracy.

Main Methods:

  • Review of existing literature on non-invasive atherosclerosis assessment techniques.
  • Analysis of the predictive value of coronary artery calcification, ankle-brachial index, and carotid intima-media thickness for HF.
  • Examination of the role of left ventricular ejection fraction in HF risk prediction.

Main Results:

  • Non-invasive atherosclerosis assessments are superior to traditional methods for predicting atherosclerotic cardiovascular disease risk.
  • These modalities show promise in assessing HF risk, particularly when left ventricular ejection fraction is reduced.
  • Predicting HF with preserved ejection fraction using these measures is challenging due to the condition's heterogeneity.

Conclusions:

  • Non-invasive atherosclerosis assessments offer valuable insights into heart failure risk.
  • The predictive power is enhanced in cases of reduced ejection fraction, often linked to coronary artery disease.
  • Further research is essential to improve HF with preserved ejection fraction risk prediction.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
19
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
23
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
24
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
19
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
21
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
55